Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone versus placebo for carotid intima-media thickness in non-diabetic atherosclerosis
2006-000171-15Phase 2Completed
- Sponsor
- University Hospital Ulm
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atherosclerosis comparing Pioglitazone add-on with Placebo add-on (2 arms). Primary endpoint: Change in total vessel wall volume of the carotid bulbus/bifurcation. Started Sep 2006; status: completed.
02
Drugs
pioglitazone
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on 2006-000171-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000171-15.